Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Magic mushroom compound tested as One-Time depression fix for cancer patients

NCT ID NCT06319378

First seen Apr 29, 2026 · Last updated May 19, 2026 · Updated 5 times

Summary

This study tests whether a single 25 mg dose of psilocybin (the active ingredient in magic mushrooms) can ease major depression in 100 adults with cancer. Participants are randomly assigned to receive either the full dose or a very low placebo dose, and depression levels are tracked for 42 days. The goal is to see if this one-time treatment can quickly improve mood without the need for ongoing medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MDD are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Norra Stockholms Psykiatri

    RECRUITING

    Stockholm, Stockholm County, Sweden

    Contact

    Contact Email: •••••@•••••

  • Psykiatriska Kliniken, Akademiska Sjukhuset

    RECRUITING

    Uppsala, Uppsala County, Sweden

    Contact Email: •••••@•••••

    Contact

  • region Västra Götaland

    RECRUITING

    Gothenburg, Göteborg, Sweden

    Contact Email: •••••@•••••

    Contact

  • Örebro sjukhus

    RECRUITING

    Örebro, Örebro County, Sweden

    Contact

    Contact Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.